Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$24,789,557
+$7,485,621 QoQ
Shares Held
98,512
+23.8% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
1.33%
of 13F equity value
Holder Rank
#541
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MEEDER ASSET MANAGEMENT INC holds $140,500,918 across 9 Drug Manufacturers - General names. ABBV ranks #3 (17.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
28,922 | $34,689,912 | |
| 2 | JNJ |
Johnson & Johnson
|
117,192 | $29,763,248 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
98,512 | $24,789,557 | |
| 4 | AMGN |
Amgen Inc
|
65,451 | $23,701,113 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
135,547 | $17,125,003 | |
| 6 | MRK |
Merck & Co., Inc.
|
71,755 | $9,220,516 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
20,426 | $1,176,942 | |
| 8 | PFE |
Pfizer Inc
|
1,115 | $26,849 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,789,557 | 98,512 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $17,303,936 | 79,562 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $15,989,269 | 69,978 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $12,616,842 | 54,491 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $14,762,541 | 79,531 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $10,674,413 | 50,947 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,020,626 | 11,371 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $35,982,827 | 182,210 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $19,316,067 | 112,617 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $4,860,066 | 26,689 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $22,083,844 | 142,504 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $475,650 | 3,191 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $12,239,816 | 90,847 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $14,264,885 | 89,508 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,982,926 | 55,584 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $14,899,318 | 111,015 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $16,963,385 | 110,756 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $21,810,277 | 134,540 | Shares | Defined | 2022-05-10 | |
| 2021-09-30 | $13,720,737 | 127,197 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $14,406,768 | 127,901 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $13,477,825 | 124,541 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $1,869,231 | 17,445 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $10,727,581 | 122,475 | Shares | Defined | 2020-11-02 | |
| 2020-06-30 | $11,956,161 | 121,778 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $7,612,216 | 99,911 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||